2026 Self-Insurance Institute of America National Conference in Phoenix

The cell and gene therapy landscape isn’t slowing down, and neither are the questions facing self-insured payers.

Those questions were front and center on Tuesday, Oct. 13, when Emerging Therapy Solutions’ CEO Ashley Hume presented in a breakout session at the 2026 Self-Insurance Institute of America (SIIA) National Conference.

Ashley looked at the major CGT developments shaping 2026 and what’s ahead as self-insured organizations navigate increasingly complex decisions around coverage, access and financial risk.

For ETS, these conversations are central to our work. For 30+ years, ETS has helped organizations anticipate what’s ahead and build strategies that support patients while protecting plan sustainability for transplant, cell & gene therapies, and what’s next.